The breast cancer chemoprevention debate.

Journal of the National Cancer Institute

Volumn 103, Issue 22, 2011, Pages 1646-1647

  Schmidt, Charlie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; EXEMESTANE; NITRILE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRIAZOLE DERIVATIVE;

BREAST TUMOR; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; NOTE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ANDROSTADIENES; ANTICARCINOGENIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOPREVENTION; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MODELS, STATISTICAL; NITRILES; RALOXIFENE; RISK ASSESSMENT; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRIAZOLES;

EID: 84855499572     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr479     Document Type: Note

References (0)